Kyung Nam Pharm Announces 19.1 Billion Won Rights Offering at 1,735 Won per Share, Diluting 70%

Kyung Nam Pharm decided to issue 11 million new shares to raise 19.085 billion won for operating funds
The tentative issue price is 1,735 won, a discount of approximately 36% compared to the current price of 2,710 won
Existing shareholders receive 0.7040881405 new shares per held share, diluting existing equity by about 70%
Record date for rights is June 25, 2026; subscription period for existing shareholders is August 3-4, 2026
New shares are expected to be listed on August 24, 2026; lead underwriter is SK Securities
Funds are intended for operating purposes, not for facility investment or debt repayment